Co-Founder, CEO
A structural biologist, Geoffrey has worked on the development of toxin-based therapeutics for more than 15 years, including academic collaborations with Ipsen BioInnovation (UK), and Applied Molecular Transport Inc. (USA) at the University of Bath (UK) and Stockholm University (Sweden).
Co-Founder, Vice-CEO
Pål has more than 20 years experience in academia working on structure-based drug design and research on the botulinum neurotoxins.
Pål is Professor of Neurochemistry at Stockholm University (Sweden).
Principal Scientist
Sara is a protein biochemist and specialist of the botulinum neurotoxins.
Member of the DRIVE Incubator
Copyright © All Rights Reserved
